Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Non-Current Debt (2016 - 2021)

Arcadia Biosciences (RKDA) has disclosed Non-Current Debt for 7 consecutive years, with $78000.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Non-Current Debt fell 96.94% year-over-year to $78000.0, compared with a TTM value of $78000.0 through Sep 2021, down 96.94%, and an annual FY2020 reading of $2.1 million, up 1867.29% over the prior year.
  • Non-Current Debt was $78000.0 for Q3 2021 at Arcadia Biosciences, down from $87000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $23.1 million in Q1 2017 and bottomed at $78000.0 in Q3 2021.
  • Average Non-Current Debt over 4 years is $4.7 million, with a median of $130000.0 recorded in 2020.
  • The sharpest move saw Non-Current Debt soared 2154.87% in 2020, then crashed 96.94% in 2021.
  • Year by year, Non-Current Debt stood at $21.1 million in 2017, then tumbled by 99.49% to $107000.0 in 2019, then skyrocketed by 1867.29% to $2.1 million in 2020, then crashed by 96.29% to $78000.0 in 2021.
  • Business Quant data shows Non-Current Debt for RKDA at $78000.0 in Q3 2021, $87000.0 in Q2 2021, and $96000.0 in Q1 2021.